Clinical trial
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset…
NCT00160615 · UCB Japan Co. Ltd., Industry · Completed
Key facts
| NCT number | NCT00160615 |
|---|---|
| Title | Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method |
| Official title | Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method |
| Lead sponsor | UCB Japan Co. Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 154 |
| Start date | Sep 12, 2001 |
| Primary completion | Jan 17, 2007 |
| Completion | Jan 17, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 10, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: